ALKEMPharmaceuticals
Alkem Laboratories Ltd — Quarterly Results & Earnings
₹5299.00
-1.40%
Profit Growth YoY11.10%Latest quarter
Sales Growth YoY17.17%Latest quarter
Sales CAGR 5Y9.21%5 year compound
Profit CAGR 5Y13.93%5 year compound
📋
Quarterly Performance
YoY Profit Growth+11.10%
✅ Strong growth
YoY Sales Growth+17.17%
✅ Strong growth
OPM 5Y Average
18.30%Operating profit margin
EPS Growth 5Y
13.93%Interest Coverage
22.52Higher = safer debt servicing
ROE
19.39%ROCE
20.38%💡
Growth Analysis
Alkem Laboratories Ltd reported YoY profit growth of 11.10% and revenue growth of 17.17% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 9.21% and profits at 13.93% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Alkem Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.